Proteomics and metabolomics delve into the dynamic functional layers of biological systems, offering critical insights beyond genomic information. Proteomics focuses on large-scale analysis of protein expression, structure, interactions, and post-translational modifications, shedding light on cellular behavior and disease mechanisms. Metabolomics, on the other hand, profiles the complete set of small-molecule metabolites within a biological system, providing a snapshot of physiological states and metabolic changes in real time. These disciplines are instrumental in biomarker discovery, drug development, systems biology, and personalized medicine. Advanced tools such as mass spectrometry, NMR spectroscopy, and bioinformatics platforms are essential in navigating the complexity of biological networks. Proteomics and metabolomics collectively contribute to understanding disease progression, optimizing therapeutics, and predicting treatment outcomes with unparalleled precision.
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Steps and strides: Cross-species insights into movement and injury
Babak Faramarzi, Western University of Health Sciences, United States
Title : Eliminating implant failure in humans with nano chemistry: 45,000 cases and counting
Thomas J Webster, Brown University, United States
Title : Scientist’s computational lawyer
Julia Sidorova, Instituto Carlos III de Salud (CIBER-EHD), Spain
Title : Evaluating cell compatibility and subcutaneous host response of silk fibroin–chitosan plug composites as potential resorbable implants
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico